These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 25269440

  • 1. Bifidobacterium animalis subsp. lactis decreases urinary oxalate excretion in a mouse model of primary hyperoxaluria.
    Klimesova K, Whittamore JM, Hatch M.
    Urolithiasis; 2015 Apr; 43(2):107-17. PubMed ID: 25269440
    [Abstract] [Full Text] [Related]

  • 2. Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter.
    Hatch M, Gjymishka A, Salido EC, Allison MJ, Freel RW.
    Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G461-9. PubMed ID: 21163900
    [Abstract] [Full Text] [Related]

  • 3. Oxalobacter formigenes produces metabolites and lipids undetectable in oxalotrophic Bifidobacterium animalis.
    Chamberlain CA, Hatch M, Garrett TJ.
    Metabolomics; 2020 Nov 21; 16(12):122. PubMed ID: 33219444
    [Abstract] [Full Text] [Related]

  • 4. Oxalobacter formigenes colonization normalizes oxalate excretion in a gastric bypass model of hyperoxaluria.
    Canales BK, Hatch M.
    Surg Obes Relat Dis; 2017 Jul 21; 13(7):1152-1157. PubMed ID: 28552742
    [Abstract] [Full Text] [Related]

  • 5. Oxalobacter formigenes treatment confers protective effects in a rat model of primary hyperoxaluria by preventing renal calcium oxalate deposition.
    Verhulst A, Dehmel B, Lindner E, Akerman ME, D'Haese PC.
    Urolithiasis; 2022 Apr 21; 50(2):119-130. PubMed ID: 35122487
    [Abstract] [Full Text] [Related]

  • 6. A human strain of Oxalobacter (HC-1) promotes enteric oxalate secretion in the small intestine of mice and reduces urinary oxalate excretion.
    Hatch M, Freel RW.
    Urolithiasis; 2013 Oct 21; 41(5):379-84. PubMed ID: 23959075
    [Abstract] [Full Text] [Related]

  • 7. Induction of enteric oxalate secretion by Oxalobacter formigenes in mice does not require the presence of either apical oxalate transport proteins Slc26A3 or Slc26A6.
    Hatch M.
    Urolithiasis; 2020 Feb 21; 48(1):1-8. PubMed ID: 31201468
    [Abstract] [Full Text] [Related]

  • 8. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
    Troxel SA, Sidhu H, Kaul P, Low RK.
    J Endourol; 2003 Apr 21; 17(3):173-6. PubMed ID: 12803990
    [Abstract] [Full Text] [Related]

  • 9. Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria?
    Hoppe B, von Unruh G, Laube N, Hesse A, Sidhu H.
    Urol Res; 2005 Nov 21; 33(5):372-5. PubMed ID: 16284877
    [Abstract] [Full Text] [Related]

  • 10. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
    Tavasoli S, Alebouyeh M, Naji M, Shakiba Majd G, Shabani Nashtaei M, Broumandnia N, Basiri A.
    BJU Int; 2020 Jan 21; 125(1):133-143. PubMed ID: 31145528
    [Abstract] [Full Text] [Related]

  • 11. Impact of dietary calcium and oxalate, and Oxalobacter formigenes colonization on urinary oxalate excretion.
    Jiang J, Knight J, Easter LH, Neiberg R, Holmes RP, Assimos DG.
    J Urol; 2011 Jul 21; 186(1):135-9. PubMed ID: 21575973
    [Abstract] [Full Text] [Related]

  • 12. Effect of a Probiotic Supplement Containing Lactobacillus Acidophilus and Bifidobacterium Animalis Lactis on Urine Oxalate in Calcium Stone Formers with Hyperoxaluria: A Randomized, Placebo-controlled, Double-blind and In-vitro Trial.
    Tavasoli S, Jalali S, Naji M, Borumandnia N, Shakiba Majd G, Basiri A, Khosravi Darani K, Karamad D, Tajabadi-Ebrahimi M, Taheri M.
    Urol J; 2021 Jun 15; 19(3):179-188. PubMed ID: 34129232
    [Abstract] [Full Text] [Related]

  • 13. [Effect of oral lactosucrose supplementation on human enteric oxalate-degrading bacteria].
    Takei K, Akakura K, Ueda T, Mikami K, Ito H.
    Hinyokika Kiyo; 2006 Sep 15; 52(9):687-91. PubMed ID: 17040052
    [Abstract] [Full Text] [Related]

  • 14. Sel1-like proteins and peptides are the major Oxalobacter formigenes-derived factors stimulating oxalate transport by human intestinal epithelial cells.
    Arvans D, Chang C, Alshaikh A, Tesar C, Babnigg G, Wolfgeher D, Kron S, Antonopoulos D, Bashir M, Cham C, Musch M, Chang E, Joachimiak A, Hassan H.
    Am J Physiol Cell Physiol; 2023 Jul 01; 325(1):C344-C361. PubMed ID: 37125773
    [Abstract] [Full Text] [Related]

  • 15. Oxalobacter formigenes-Derived Bioactive Factors Stimulate Oxalate Transport by Intestinal Epithelial Cells.
    Arvans D, Jung YC, Antonopoulos D, Koval J, Granja I, Bashir M, Karrar E, Roy-Chowdhury J, Musch M, Asplin J, Chang E, Hassan H.
    J Am Soc Nephrol; 2017 Mar 01; 28(3):876-887. PubMed ID: 27738124
    [Abstract] [Full Text] [Related]

  • 16. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
    Siva S, Barrack ER, Reddy GP, Thamilselvan V, Thamilselvan S, Menon M, Bhandari M.
    BJU Int; 2009 Jan 01; 103(1):18-21. PubMed ID: 19021605
    [Abstract] [Full Text] [Related]

  • 17. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1.
    Hoppe B, Beck B, Gatter N, von Unruh G, Tischer A, Hesse A, Laube N, Kaul P, Sidhu H.
    Kidney Int; 2006 Oct 01; 70(7):1305-11. PubMed ID: 16850020
    [Abstract] [Full Text] [Related]

  • 18. Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion.
    Hatch M, Cornelius J, Allison M, Sidhu H, Peck A, Freel RW.
    Kidney Int; 2006 Feb 01; 69(4):691-8. PubMed ID: 16518326
    [Abstract] [Full Text] [Related]

  • 19. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
    Sidhu H, Schmidt ME, Cornelius JG, Thamilselvan S, Khan SR, Hesse A, Peck AB.
    J Am Soc Nephrol; 1999 Nov 01; 10 Suppl 14():S334-40. PubMed ID: 10541258
    [Abstract] [Full Text] [Related]

  • 20. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration.
    Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, Stefoni S, Pirovano F, Centi C, Ulisse S, Famularo G, De Simone C.
    Kidney Int; 2001 Sep 01; 60(3):1097-105. PubMed ID: 11532105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.